🔎 Trials Near Me

Nyumbani › Limfoma ya Selu B

Majaribio ya kliniki ya Limfoma ya Selu B yanayovutia washiriki nchini Marekani

Masomo 67 ya Limfoma ya Selu B yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06343311

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

InaajiriUtafiti wa uchunguzi
Umri 0 hadi 38 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06131801

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07439653

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06350318

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07101328

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT05615636

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

InaajiriHatua 1/2
31 Days – 30 Years · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT04544592

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06526793

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT05272384

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06564038

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06393738

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

InaajiriUtafiti wa uchunguzi
Umri 4 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07652580

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Ago 2026 · NCT07516093

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07520006

A Study of ARC-02 in B-cell NHL

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT07691606

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

InaajiriHatua 1
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT05389423

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT05826535

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.